The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
Open accessAbstract
Osteosarcoma is the most common primary malignant tumor of bone. Analysis of familial cancer syndromes and sporadic cases has strongly implicated both p53 and pRb in its pathogenesis; however, the relative contribution of these mutations to the initiation of osteosarcoma is unclear. We describe here the generation and characterization of a genetically engineered mouse model in which all animals develop short latency malignant osteosarcoma. The genetically engineered mouse model is based on osteoblast-restricted deletion of p53 and pRb . Osteosarcoma development is dependent on loss of p53 and potentiated by loss of pRb, revealing a dominance of p53 mutation in the development of osteosarcoma. The model reproduces many of the defining features of human osteosarcoma including cytogenetic complexity and comparable gene expression signatures, histology, and metastatic behavior. Using a novel in silico methodology termed cytogenetic region enrichment analysis, we demonstrate high conservation of gene expression changes between murine osteosarcoma and known cytogentically rearranged loci from human osteosarcoma. Due to the strong similarity between murine osteosarcoma and human osteosarcoma in this model, this should provide a valuable platform for addressing the molecular genetics of osteosarcoma and for developing novel therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., & Berns, A. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,053
Rodda, S. J., & McMahon, A. P. (2006) · Development · doi:10.1242/dev.02480 · Cited by 1,010
Self-citationRequirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., & te Rielef, H. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,008
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L., & Strasser, A. (2007) · Science · doi:10.1126/science.1142596 · Cited by 827
Buried alive: How osteoblasts become osteocytes
Franz‐Odendaal, T. A., Hall, B. K., & Witten, P. E. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20603 · Cited by 795
Maximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.031 · Cited by 717
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
The mighty mouse: genetically engineered mouse models in cancer drug development
Sharpless, N. E., & DePinho, R. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2110 · Cited by 661
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
SSEA-4 identifies mesenchymal stem cells from bone marrow
Gang, E. J., Bosnakovski, D., Figueiredo, C. A., Visser, J. W., & Perlingeiro, R. C. R. (2007) · Blood · doi:10.1182/blood-2005-11-010504 · Cited by 509
Mesenchymal Stem Cell Features of Ewing Tumors
Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., & Delattre, O. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.027 · Cited by 507
G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow
Semerad, C. L., Christopher, M. J., Liu, F., Short, B., Simmons, P. J., Winkler, I., Levesque, J.-P., Chappel, J., Ross, F. P., & Link, D. C. (2005) · Blood · doi:10.1182/blood-2004-01-0272 · Cited by 500
Liu, X., Holstege, H., van der Gulden, H., Treur-Mulder, M., Zevenhoven, J., Velds, A., Kerkhoven, R. M., van Vliet, M. H., Wessels, L. F. A., Peterse, J. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702969104 · Cited by 474
Regulation of Osteoblast Formation and Function
Aubin, J. E. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010011209064 · Cited by 465
Mechanisms of sarcoma development
Helman, L. J., & Meltzer, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1168 · Cited by 460
Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow Microenvironment
Walkley, C. R., Shea, J. M., Sims, N. A., Purton, L. E., & Orkin, S. H. (2007) · Cell · doi:10.1016/j.cell.2007.03.055 · Cited by 424
Self-citationAn oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
McClatchey, A. I., Saotome, I., Mercer, K., Crowley, D., Gusella, J. F., Bronson, R. T., & Jacks, T. (1998) · Genes & Development · doi:10.1101/gad.12.8.1121 · Cited by 388
Roots and stems: stem cells in cancer
Polyak, K., & Hahn, W. C. (2006) · Nature Medicine · doi:10.1038/nm1379 · Cited by 378
Thomas, D. M., Carty, S. A., Piscopo, D. M., Lee, J.-S., Wang, W.-F., Forrester, W. C., & Hinds, P. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00327-6 · Cited by 361
Osteoblasts are target cells for transformation in c-fos transgenic mice
Grigoriadis, A., Schellander, K., Wang, Z., & Wagner, E. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.685 · Cited by 350
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
Haldar, M., Hancock, J. D., Coffin, C. M., Lessnick, S. L., & Capecchi, M. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.016 · Cited by 326
Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes
Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., Karnoub, A. E., Iglehart, J. D., & Weinberg, R. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.013 · Cited by 309
Conditional mouse models of sporadic cancer
Jonkers, J., & Berns, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc777 · Cited by 294
H2AX Prevents DNA Breaks from Progressing to Chromosome Breaks and Translocations
Franco, S., Gostissa, M., Zha, S., Lombard, D. B., Murphy, M. M., Zarrin, A. A., Yan, C., Tepsuporn, S., Morales, J. C., Adams, M. M., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.005 · Cited by 282
Self-citationMolecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
Osteoblast differentiation and skeletal development are regulated by Mdm2–p53 signaling
Lengner, C. J., Steinman, H. A., Gagnon, J., Smith, T. W., Henderson, J. E., Kream, B. E., Stein, G. S., Lian, J. B., & Jones, S. N. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200508130 · Cited by 265
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00105-5 · Cited by 262
Mutation spectrum of the retinoblastoma gene in osteosarcomas.
Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., & Yamamuro, T. (1994) · PubMed · Cited by 250
Genetically Engineered Models Have Advantages over Xenografts for Preclinical Studies
Becher, O. J., & Holland, E. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3827 · Cited by 243
The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207074 · Cited by 224
Isakoff, M. S., Sansam, C. G., Tamayo, P., Subramanian, A., Evans, J. A., Fillmore, C. M., Wang, X., Biegel, J. A., Pomeroy, S. L., Mesirov, J. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509014102 · Cited by 214
Frequency and structure of p53 rearrangements in human osteosarcoma.
Miller, C. W., Aslo, A., Tsay, C., Slamon, D. J., Ishizaki, K., Toguchida, J., Yamamuro, T., Lampkin, B. C., & Koeffler, H. P. (1990) · PubMed · Cited by 210
Terminal osteoblast differentiation, mediated by runx2 and p27 KIP1, is disrupted in osteosarcoma
Thomas, D. M., Johnson, S. A., Sims, N. A., Trivett, M. K., Slavin, J. L., Rubin, B. P., Waring, P., McArthur, G. A., Walkley, C. R., Holloway, A. J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200409187 · Cited by 208
Self-citationc-fos expression induces bone tumors in transgenic mice.
Rüther, U., Komitowski, D. D., Schubert, F., & Wagner, E. F. (1989) · PubMed · Cited by 184
Tsuchiya, T., Sekine, K.-I., Hinohara, S.-I., Namiki, T., Nobori, T., & Kaneko, Y. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00255-1 · Cited by 179
Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature
Bridge, J. A., Nelson, M., McComb, E., McGuire, M. H., Rosenthal, H., Vergara, G., Maale, G. E., Spanier, S., & Neff, J. R. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00306-8 · Cited by 171
Tamayo, P., Scanfeld, D., Ebert, B. L., Gillette, M. A., Roberts, C. W. M., & Mesirov, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701068104 · Cited by 155
TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter Study
Wunder, J. S., Gökgöz, N., Parkes, R. K., Bull, S. B., Eskandarian, S., Davis, A. M., Beauchamp, C. P., Conrad, E. U., Grimer, R. J., Healey, J. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.074 · Cited by 144
Conditional Mutation of Rb Causes Cell Cycle Defects without Apoptosis in the Central Nervous System
MacPherson, D. P., Sage, J., Crowley, D. G., Trumpp, A., Bronson, R. T., & Jacks, T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1044-1053.2003 · Cited by 144
Wang, Z., Liang, J., Schellander, K., Wagner, E. F., & Grigoriadis, A. E. (1995) · PubMed · Cited by 140
Li, Z., Tognon, C. E., Godinho, F. J., Yasaitis, L. C., Hock, H. R., Herschkowitz, J. I., Lannon, C. L., Cho, E., Kim, S., Bronson, R. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.11.012 · Cited by 138
Self-citationAlterations of the p15, p16, and p18 genes in osteosarcoma
Miller, C. W., Aslo, A., Campbell, M. J., Kawamata, N., Lampkin, B. C., & Koeffler, H. P. (1996) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00216-2 · Cited by 103
Role of the Retinoblastoma Protein in Differentiation and Senescence
Thomas, D. M., Yang, H.-S., Alexander, K., & Hinds, P. W. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.2.235 · Cited by 100
Commonly used mouse models of osteosarcoma
Ek, E. T., Dass, C. R., & Choong, P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.03.006 · Cited by 87
Technologically advanced cancer modeling in mice
Tuveson, D. A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00272-6 · Cited by 80
A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families
Porter, D. E., Holden, S., Steel, C., Bb, C., Wallace, M., & Reid, R. (1992) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.74b6.1447251 · Cited by 75
Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma
Pakos, E. E., Kyzas, P., & Ioannidis, J. P. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0246 · Cited by 71
Specific TP53 mutation pattern in radiation-induced sarcomas
Britzen‐Laurent, N., Gibaud, A., Huygue, M., Lefèvre, S.-H., Bras, M. L., Chauveinc, L., Sastre‐Garau, X., Doz, F., Rouïc, L. L.-L., Chevillard, S., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi356 · Cited by 66
Mouse Models of Human Non-Small-Cell Lung Cancer: Raising the BarPreprint
KIM, C. F. B., Jackson, E. L., Kirsch, D. G., Grimm, J., Shaw, A. T., Lane, K. M., Kissil, J. L., Olive, K. P., Sweet-Cordero, A., Weissleder, R., et al. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.037 · Cited by 59
RB1 and TP53 pathways in radiation-induced sarcomas
Gonin-Laurent, N., Hadj-Hamou, N.-S., Vogt, N., Houdayer, C., Gauthier‐Villars, M., Dehainault, C., Sastre‐Garau, X., Chevillard, S., & Malfoy, B. (2007) · Oncogene · doi:10.1038/sj.onc.1210404 · Cited by 53
The p19INK4D Cyclin dependent kinase inhibitor gene is altered in osteosarcoma
Miller, C. W., Yeon, C., Aslo, A., Mendoza, S., Aytac, U., & Koeffler, H. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201185 · Cited by 35
Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes
Mendoza, S., David, H., Gaylord, G. M., & Miller, C. W. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.035 · Cited by 28
Tan, J. Z.-Y., Schlicht, S., Powell, G. J., Thomas, D. M., Slavin, J., Smith, P. J., & Choong, P. (2006) · International Seminars in Surgical Oncology · doi:10.1186/1477-7800-3-38 · Cited by 24
The NF2 gene and merlin protein in human osteosarcomas
Stemmer-Rachamimov, A. O., Nielsen, G. P., Rosenberg, A. E., et al. (1998) · Neurogenetics · doi:10.1007/s100480050054 · Cited by 21
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
Cited by
Advancing therapy for osteosarcoma
Gill, J., & Gorlick, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00519-8 · Cited by 876
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752
Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481
Self-citationLindsey, B. A., Markel, J. E., & Kleinerman, E. S. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-016-0050-2 · Cited by 487
Molecular Biology of Osteosarcoma
Czarnecka, A. M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., Grieb, P., & Rutkowski, P. (2020) · Cancers · doi:10.3390/cancers12082130 · Cited by 336
Metadata
- Authors
- Walkley, C. R., Qudsi, R., Sankaran, V. G., Perry, J. A., Gostissa, M., Roth, S. I., Rodda, S. J., Snay, E., Dunning, P., Fahey, F. H., Alt, F. W., McMahon, A. P., & Orkin, S. H.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2008-06-15
- Volume
- 22
- Issue
- 12
- Pages
- 1662-1676
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2139958117
- Cited by
- 373
- References
- 70
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.